Prevention of vascular calcification: is pyrophosphate therapy a solution?
Authors:
- Veerle P. PersyVPVeerle P. Persy
- Marc D. McKeeMMMarc D. McKee
- 1 March 2011
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 79 (5) , 490-493
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment with pyrophosphate inhibits uremic vascular calcificationKidney International, 2011
- Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2006
- Inhibition of the Progression of Aortic Calcification by Etidronate Treatment in Hemodialysis Patients: Long‐Term EffectsTherapeutic Apheresis and Dialysis, 2006
- Effect of Etidronic Acid on Arterial Calcification in Dialysis PatientsClinical Drug Investigation, 2006
- Regression of Medial Elastocalcinosis in Rat AortaCirculation, 2005
- Natural history of vascular calcification in dialysis and transplant patientsNephrology Dialysis Transplantation, 2004
- Concerted Regulation of Inorganic Pyrophosphate and Osteopontin by Akp2, Enpp1, and AnkThe American Journal of Pathology, 2004
- Novel Cardiovascular Risk Factors in End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2004
- Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortalityNephrology Dialysis Transplantation, 2003
- Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient MiceJournal of Experimental Medicine, 2002